Zobrazeno 1 - 10
of 38
pro vyhledávání: '"M Sánchez-Azofra"'
Autor:
M. D. Martin-Arranz, L. García-Ramírez, M. Hernandez-Perez, D. Montero Vega, E. Martín-Arranz, M. Sánchez-Azofra, J. Poza Cordon, J. L. Rueda Garcia, J. Noci Belda, T. Verges Martínez-Meco, P. Blanco San Miguel, C. Suarez Ferrer
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract Patients with inflammatory bowel disease (IBD) treated with biologic and/or immunosuppressant drugs are at increased risk for opportunistic infections. Seroprevalence studies can confirm the diagnosis of SARS-CoV-2 infections as well as the
Externí odkaz:
https://doaj.org/article/efcb1819ab6e4a0593b0272ac1fe66f2
Autor:
L García Ramírez, C Suárez Ferrer, J L Rueda Garcia, E Martín-Arranz, J Poza Cordón, M Sánchez-Azofra, M D Martin-Arranz
Publikováno v:
Journal of Crohn's and Colitis. 17:i952-i953
Background Given the low immunogenicity of ustekinumab (UST), it has been suggested that it is not necessary to add an immunomodulator (IMM). However, there is little scientific evidence on whether the efficacy of combined UST+IMM treatment may be gr
Autor:
J M Arroyo Argüelles, C Suárez Ferrer, J L Rueda García, E Martín-Arranz, J Poza Cordón, M Sánchez-Azofra, L García-Ramírez, M D Martin-Arranz
Publikováno v:
Journal of Crohn's and Colitis. 17:i866-i866
Background There is little scientific evidence available about the results in terms of clinical and biochemical response after intensification with intravenous (IV) ustekinumab (UST) as a therapeutic strategy to be used in patients with refractory Cr
Autor:
C Amor Costa, C Suárez Ferrer, J Poza Cordón, J Yebra Carmona, J L Rueda García, M Sánchez Azofra, E Martín Arranz, I González Díaz, C Amiama Roig, M D Martín Arranz
Publikováno v:
Journal of Crohn's and Colitis. 17:i494-i494
Background Ileocolonoscopy is the gold standard to evaluate post-operative recurrence (POR) in Crohn's disease (CD) patients. Rutgeerts endoscopic score remains the gold standard in the evaluation of post-operative recurrence in CD. Intestinal ultras
Autor:
M D Martin Arranz, L García Ramírez, D Montero Vega, E Martín-Arraz, M Sánchez Azofra, J Poza Cordon, J L Rueda Garcia, J Noci Belda, T Verges Martínez-Meco, P Blanco San Miguel, C Suarez Ferrer
Publikováno v:
Journal of Crohn's and Colitis. 16:i533-i534
Background Our objective is to evaluate the serologic response to the SARS-CoV-2 vaccine in patients with Inflammatory Bowel Disease (IBD). In addition to that, we want to analyze the influence of immunosuppressive drugs in that response, as well as
Autor:
M J Casanova, M Chaparro, Ó Nantes, P Varela, M Vela-González, R Montserrat, O G Sierra, S Riestra, M Barreiro-de Acosta, M M Martín-Rodríguez, C J Gargallo-Puyuelo, C Reygosa, R Muñoz, I García de la Filia-Molina, A Núñez-Ortiz, L Kolle, M Calafat, J M Huguet, E Iglesias-Flores, T J Martínez-Pérez, O Bosch, J M Duque-Alcorta, S Frago-Larramona, M Sánchez-Azofra, M Van Domselaar, V M González-Cosano, L Bujanda, S Rubio, A Mancebo, B Castro, S García-López, R de Francisco, L Nieto, V Laredo, A Gutiérrez, F Mesonero, E Leo-Carnerero, F Cañete, L Ruiz, J P Gisbert
Publikováno v:
Journal of Crohn's and Colitis. 16:i474-i475
Background Aims: 1) to compare persistence on adalimumab treatment over time in inflammatory bowel disease (IBD) patients who maintained adalimumab reference [non-switch cohort (NC)] vs. those who switched from adalimumab reference to adalimumab bios
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M Sánchez Azofra, E Martín Arranz, I. M. Spigarelli De Rábago, C. G. S. Suárez Cabredo, M. Hernández Pérez, C Suárez Ferrer, J Poza Cordón, M D Martín Arranz, J L Rueda García
Publikováno v:
Journal of Crohn's and Colitis. 15:S270-S271
Background Fecal calprotectin (FC) has become a fundamental tool in the non-invasive monitorization of activity in patients with inflammatory bowel diseases (IBD). However, there is still debate over the choice of the optimal cut-off point for the di
Autor:
J Poza Cordón, C Suárez Ferrer, J L Rueda García, I González Diaz, M D Martín Arranz, M Sánchez Azofra, L García Ramirez, C Amor Costa, E Martín Arranz, C Amiama Roig
Publikováno v:
Journal of Crohn's and Colitis. 15:S534-S534
Background Thiopurines (TP) are widely used in monotherapy in patients with ulcerative colitis (UC), mainly for the maintenance of remission in case of corticodependence or corticoresistance after cyclosporine use. However, these are drugs with signi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.